2 news items
MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024
AFMD
ALBT
BPTH
4 Jun 24
of traders and investors with its innovative approaches to cancer treatment, focusing on telomere-targeting therapies. The company is scheduled to present
Avalon GloboCare Extends Exclusivity Agreement To Distribute KetoAir Breathalyzer Device And AI-Enabled Software In North America, South America, United Kingdom And European Union
ALBT
28 Mar 24
that uses an AI nutritionist bundled with a nanosensor-based breathalyzer for ketogenic health management. Our primary focus will be on targeting
- Prev
- 1
- Next